Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-29 4:55 pm Purchase |
2021-01-25 | 13D | Zymeworks Inc. ZYME |
Baker Bros. Advisors LP | 4,909,810 9.990% |
47,396 (+0.97%) |
Filing History |
| 2021-01-29 4:48 pm Purchase |
2021-01-22 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,126,417 28.800% |
5,189 (+0.05%) |
Filing History |
| 2021-01-29 4:38 pm Sale |
2020-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Baker Bros. Advisors LP | 546,037 12.100% |
-6,446 (-1.17%) |
Filing History |
| 2021-01-05 5:14 pm Sale |
2021-01-05 | 13D | IGM Biosciences, Inc. IGMS |
Baker Bros. Advisors LP | 3,157,271 12.400% |
-35,751 (-1.12%) |
Filing History |
| 2020-12-23 5:11 pm Purchase |
2020-07-07 | 13D | Neoleukin Therapeutics, Inc. NLTX |
Baker Bros. Advisors LP | 211,491 9.990% |
21,241 (+11.16%) |
Filing History |
| 2020-12-11 5:28 pm Purchase |
2020-12-07 | 13D | IGM Biosciences, Inc. IGMS |
Baker Bros. Advisors LP | 3,193,022 9.990% |
49,022 (+1.56%) |
Filing History |
| 2020-12-04 5:24 pm Sale |
2020-12-01 | 13D | BeiGene, Ltd. ONC |
Baker Bros. Advisors LP | 154,315,490 13.000% |
-19,650,098 (-11.30%) |
Filing History |
| 2020-11-24 4:12 pm Purchase |
2020-11-20 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 14,054,698 27.600% |
1,778,949 (+14.49%) |
Filing History |
| 2020-09-30 5:25 pm Purchase |
2020-09-24 | 13D | Prelude Therapeutics Incorporated PRLD |
Baker Bros. Advisors LP | 10,121,228 31.100% |
10,121,228 (New Position) |
Filing History |
| 2020-09-08 5:24 pm Purchase |
2020-09-03 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 12,275,749 27.300% |
701,212 (+6.06%) |
Filing History |
| 2020-07-28 5:29 pm Purchase |
2020-07-21 | 13D | Kiniksa Pharmaceuticals, Ltd. KNSA |
Baker Bros. Advisors LP | 2,903,030 9.200% |
6,253 (+0.22%) |
Filing History |
| 2020-07-17 5:22 pm Purchase |
2020-07-12 | 13D | BeiGene, Ltd. ONC |
Baker Bros. Advisors LP | 173,965,588 14.900% |
14,846,728 (+9.33%) |
Filing History |